Neurocrine Biosciences shares owned by Impax Asset Management Group
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Impax Asset Management Group
from 13F filings
Historical chart of Impax Asset Management Group investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by Impax Asset Management Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by Impax Asset Management Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $6.9M | 50k | 137.92 |
| 2023-12-31 | $15M | 110k | 131.76 |
| 2023-09-30 | $15M | 135k | 112.50 |
| 2023-06-30 | $19M | 200k | 94.30 |
| 2023-03-31 | $20M | 200k | 101.22 |
| 2022-12-31 | $21M | 175k | 119.44 |
| 2022-09-30 | $16M | 150k | 106.21 |
| 2020-03-31 | $6.5M | 75k | 86.55 |
| 2019-09-30 | $2.0M | 22k | 90.09 |
More positions owned by Impax Asset Management Group
View all positions for Impax Asset Management Group